|
MLTX MoonLake Immunotherapeutics 1821586 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-61,805,000.00 |
| Balance Sheet |
|
Current Assets
|
$570,038,000.00 |
|
Assets
|
$573,947,000.00 |
|
Current Liabilities
|
$45,392,000.00 |
|
Liabilities
|
$145,752,000.00 |
|
Equity
|
$428,195,000.00 |
|
Shares Out
|
85106685.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-121,844,000.00 |
|
Investing Cash Flow
|
$420,000.00 |
| Market Analysis |
Market Cap
|
$1,350,643,090.95 |
|
Price
|
$15.87 |
|
BVPS
|
5.03 |
|
PB
|
3.16 |
|
EPS
|
-0.84 |
|
FCF
|
$-121,844,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:23 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
-3.53 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-10 |
-0.98 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.87 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-1.10 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MLTX documents filed with the SEC.
MLTX Filings
Clear
